🇺🇸 FDA
Pipeline program

EXPAREL

402-C-415

Approved small_molecule terminated

Quick answer

EXPAREL for Hip Fractures is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Hip Fractures
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials